| Q70309713 | 59 Inhibitors of lysosomal function |
| Q40870731 | A possible role of oxidative stress in the vanadium-induced cytotoxicity in the MC3T3E1 osteoblast and UMR106 osteosarcoma cell lines |
| Q50802274 | A spectrophotometric study of the VO(2+)-glutathione interactions. |
| Q41808113 | Anti-diabetic effects of a series of vanadium dipicolinate complexes in rats with streptozotocin-induced diabetes |
| Q41223351 | Antihypertensive effects of vanadium compounds in hyperinsulinemic, hypertensive rats |
| Q63370478 | Counterion Affects Interaction with Interfaces: The Antidiabetic Drugs Metformin and Decavanadate |
| Q28326517 | Differential dephosphorylation of the insulin receptor and its 160-kDa substrate (pp160) in rat adipocytes |
| Q36825378 | Effect of V(IV)O(dipic-Cl)(H2O)2 on Lipid Metabolism Disorders in the Liver of STZ-Induced Diabetic Rats |
| Q69099278 | Effect of vanadate administration on blood glucose and insulin levels as well as on the exocrine pancreatic function in streptozotocin-diabetic rats |
| Q54359878 | Effect of vanadate on gene expression of the insulin signaling pathway in skeletal muscle of streptozotocin-induced diabetic rats. |
| Q36300402 | Effects of vanadyl derivatives on animal models of diabetes. |
| Q34394579 | Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus |
| Q70931672 | Electron paramagnetic resonance studies and effects of vanadium in Saccharomyces cerevisiae |
| Q34268346 | Enhancing insulin action: from chemical elements to thiazolidinediones |
| Q44405692 | Formation, Preservation, and Cleavage of the Disulfide Bond by Vanadium |
| Q40693460 | Glutathione mercaptides as transport forms of metals |
| Q41223360 | In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus |
| Q73374596 | In vivo coordination structural changes of a potent insulin-mimetic agent, bis(picolinato)oxovanadium(IV), studied by electron spin-echo envelope modulation spectroscopy |
| Q71796196 | In vivo effects of peroxovanadium compounds in BB rats |
| Q71796184 | In vivo modulation of N-myristoyltransferase activity by orthovanadate |
| Q73325688 | Influence of vanadate on glycolysis, intracellular sodium, and pH in perfused rat hearts |
| Q70201936 | Inhibition of (Na,K)-ATPase by tetravalent vanadium |
| Q71796209 | Insulin-like actions of vanadate are mediated in an insulin-receptor-independent manner via non-receptor protein tyrosine kinases and protein phosphotyrosine phosphatases |
| Q47773703 | Insulin-like effects of tungstate and molybdate: mediation through insulin receptor independent pathways |
| Q33961253 | Insulin-like effects of vanadium: basic and clinical implications |
| Q72078580 | Interaction of vanadate with isolated rat parotid acini |
| Q36278853 | Isolation and characterization of vanadate-resistant mutants of Saccharomyces cerevisiae |
| Q33895238 | Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies |
| Q73774539 | Metallokinetic analysis of disposition of vanadyl complexes as insulin-mimetics in rats using BCM-ESR method |
| Q33961238 | Oxovanadium(IV) and oxovanadium(V) complexes relevant to biological systems |
| Q70624157 | Peroxovanadate but not vanadate exerts insulin-like effects in human adipocytes |
| Q72932761 | Phosphotyrosyl-protein phosphatase of TCRC-2 cells |
| Q47972169 | Stimulation of 125I-transferrin binding and 59Fe uptake in rat adipocytes by vanadate: treatment time determines apparent tissue sensitivity |
| Q74453080 | Stimulation of MAP kinase and S6 kinase by vanadium and selenium in rat adipocytes |
| Q59763563 | Synthetic analogs for oxovanadium(IV/V)–glutathione interaction: an NMR, EPR, synthetic and structural study of oxovanadium(IV/V) compounds with sulfhydryl-containing pseudopeptides and dipeptides |
| Q41129893 | Tetravalent Vanadium Releases Ferritin Iron which Stimulates Vanadium-Dependent Lipid Peroxidation |
| Q72717804 | The effect of vanadyl treatment on vascular responsiveness of streptozotocin-diabetic rats |
| Q46597579 | The effects of peroxovanadate and peroxovanadyl on glucose metabolism in vivo and identification of signal transduction proteins involved in the mechanism of action in isolated soleus muscle. |
| Q48269012 | The mechanism of vanadium-mediated developmental hypomyelination is related to destruction of oligodendrocyte progenitors through a relationship with ferritin and iron |
| Q43618312 | The system VO2+ +oxidized glutathione: a potentiometric and spectroscopic study |
| Q43594659 | Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins |
| Q36246562 | Trifluoperazine inhibits insulin action on glucose metabolism in fat cells without affecting inhibition of lipolysis |
| Q70195523 | Vanadate stimulates Na+H+ exchange activity in A431 cells |
| Q69935954 | Vanadium accumulation and subcellular distribution in relation to vanadate induced cytotoxicity in vitro |
| Q57801218 | Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus |
| Q34671607 | Vanadium in cancer treatment |
| Q37617287 | Vanadium ions stimulate DNA synthesis in Swiss mouse 3T3 and 3T6 cells |
| Q40487753 | Vanadium salts and the future treatment of diabetes |
| Q71796215 | Vanadium salts stimulate mitogen-activated protein (MAP) kinases and ribosomal S6 kinases |
| Q28068342 | Why Antidiabetic Vanadium Complexes are Not in the Pipeline of "Big Pharma" Drug Research? A Critical Review |